Unknown

Dataset Information

119. A Respiratory Syncytial Virus Prefusion F Protein (RSVPreF3) Candidate Vaccine Administered in Older Adults in a Phase I/II Randomized Clinical Trial Is Well Tolerated


ABSTRACT:

SUBMITTER: Tica J 

PROVIDER: S-EPMC7778015 | biostudies-literature | 2020 Oct

REPOSITORIES: biostudies-literature